Verkaufen. erzielt, aber einen Verlust von $7,43 Mio. 94% auf den Preis des Vortages. However, there is a case to be made that Bionano's valuation has reached an unjustifiable level. The company sells its flagship product called Saphyr system, which helps accelerate the … Die Erträge stiegen um 37,55%, aber Bionano Genomics meldete immer noch einen Gesamtverlust von $10,23 Millionen. As recently as Christmas, you could have picked some up for less than a buck. Friday, Jan 08, 2021. Trade now Follow Following Unfollow. BioNano Genomics Is About the Future, Not the Present. 13.01.2021 - SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) - Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq … 09:16 AM ET. BNGO abonnieren. What happened Shares of Bionano Genomics (NASDAQ: BNGO) had skyrocketed 19.3% as of 11:05 a.m. EDT on Friday. Bionano Genomics Bilanz/GuV: Hier finden Sie die Bilanz/GuV-Seite für den Wert Bionano Genomics Although BNGO has turned red as seen at the end of in last trading. Bionano Genomics hat im 2. Trade now Follow Following Unfollow. U.S. stocks close at all-time highs after Biden promise of more aid offsets worst jobs report since April MarketWatch. The stock currently has a share float of 4.59%. A number of equities research analysts have weighed […] Bionano Genomics, Inc. ist ein biowissenschaftliches Instrumentierungsunternehmen im Bereich der Genomanalyse. Shares of Bionano Genomics (NASDAQ:BNGO) were tumbling 6.7% lower as of 11:10 a.m EDT on Friday. Bionano Genomics (NASDAQ:BNGO) announces its next round of earnings this Tuesday, March 23.Here is Benzinga's everything-that-matters guide … The company’s stock price has collected -6.90% of loss in the last five trading sessions. Amy Conrad - Investor Relations, Juniper Point. Why Bionano Genomics Stock Is Skyrocketing Today. BNGO Bionano Genomics Aktie . BioNano Genomics (NASDAQ: BNGO) is testing an important support at the $5 level. Source: Shutterstock Since that … Bionano Genomics Inc. had a pretty favorable run when it comes to the market performance. Bionano Genomics Aktie, WKN: A2JRLZ, ISIN: US09075F1075 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen P/E. Upcoming Earnings. Follow Following Unfollow Trade now . Wie ist die Stimmung in den sozialen Medien? Bionano Genomics, Inc. (NASDAQ:BNGO) trade information. At the end of 2020 Bionano Genomics [NASDAQ:BNGO] started a rally that would soon put in over a +2500% increase in around a month. The stock’s 5-day price performance is 17.94%, and it has moved by -10.06% in 30 days. 01:34:53. Tuesday, January 19, 2021. M. Der vorherige Schlusskurs von BNGO betrug 0 USD 50, während die ausstehenden Aktien insgesamt 153 waren. Market Cap. According to TipRanks.com, DeGeeter is a 5-star analyst with an average return of 36.7% and a 45.3% success rate. 52 Week Range. Looking at the stock we see that its previous close w Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Cowen 41st Annual Health Care Conference. 26, 2021 7:47 PM ET Bionano Genomics, Inc. (BNGO) 15 Comments 4 … Bionano Genomics zeigte bei dieser Analyse interessante Ausprägungen. Die Schätzungen von 2 Analysten gehen beim Ergebnis je Aktie von durchschnittlich … I’ll go ahead and admit it now: my timing was less than ideal when I issued a bullish call on Bionano Genomics (NASDAQ: BNGO) stock on Feb. 22. Source: Connect world / S . El estocástico marca una sobreventa de la acción al cierre del mercado del día viernes, apreciando una posible caída para la reanudación del mercado el día martes, una posible entrada al mercado. The big gain came after the company announced its first-quarter results following the market close on Thursday. Kaufen. Bionano Genomics, Inc. (BNGO) registered a -3.78% downside in the last session and has traded in the green over the past 5 sessions. Bionano Genomics, Inc. (NASDAQ:BNGO): Trading Information. Was ist ROCE? EPS. P/E. Bionano Genomics (NASDAQ:BNGO) has certainly created a buzz in 2021. 5,54 USD. BioNano may cause great disruption in the field of genetics. Bionano Genomics, Inc. Common Stock. Bionano Genomics Inc. had a pretty favorable run when it comes to the market … The company, currently valued at $2.03 Billion, closed the last trade at $7.29 per share which meant it lost -$0.24 on the day or -3.19% during that session. Die Aktien von Bionano Genomics Inc. (NASDAQ: BNGO) fielen auf ein Tief von 0 USD 5032, bevor sie bei 0 USD 53 schlossen. Going into … Real-time Level 1 for Canada + USA . hutterstock.com. Bionano Genomics: Weighing The Future Prospects Against The Here And Now . Friday, January 08, 2021 . NASDAQ Composite is rising 1.44% to $14,016.81, following last session’s upward trend, Bionano Genomics’s last close was $5.96, 154.71% under its 52-week high of $15.69. The big gain came after the company announced its first-quarter results following the market close on Thursday. View detailed financial information, real-time news, videos, quotes and analysis on Bionano Genomics, Inc. (NASDAQ:BNGO). Oppenheimer analyst K. Degeeter now forecasts that the company will earn ($0.05) per share for the quarter, down from their prior estimate of […] You can read further details here Schließen? BioNano may cause great disruption in the field of genetics. USA Aktien waren höher zum Handelsschluss; Dow Jones Industrial Average kletterte um 0,62% Von Investing.com - 05.01.2021 EPS. Source: Shutterstock. It currently … It is usually expressed as a percentage and is then referred to as the EPS growth rate. Bionano Genomics January 13, 2021 GMT SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market. 05:24 PM ET. Verzögerte Preise durch NASDAQ, in USD Markt geschlossen EPS growth is an important number as it gives a suggestion of the future prospects of a company. Upcoming Earnings. Shares of Bionano Genomics (NASDAQ: BNGO) had skyrocketed 19.3% as of 11:05 a.m. EDT on Friday. In der letzten Handelssitzung sah Bionano Genomics, Inc. (NASDAQ: BNGO) 2, 650, 241 Aktien wechseln den Besitzer, wobei das Beta derzeit 0 beträgt. Kaufen. Find the latest Financials data for Bionano Genomics, Inc. Klicken … Stock analysis for Bionano Genomics Inc (BNGO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Quartal erzielte Bionano Genomics (NASDAQ:BNGO) einen Umsatz von $2,20 Mio. Bionano Genomics, Inc. (NASDAQ:BNGO)’s Biggest Investors. P/E. The stock’s 5-day price performance is 18.14%, and it has moved by 6.26% in 30 days. Bionano Genomics, Inc. (BNGO) is a San Diego based commercial-stage life sciences instrumentation concern focused on genome analysis. NASDAQ: BNGO is trading some 20% higher in Monday's pre-market trading. Financials . Hoch 15,685. The recent highlights section of Bionano Genomics’ (NASDAQ: BNGO) 2021 first-quarter report said it all about BNGO stock. Bionano Genomics Inc. [NASDAQ: BNGO] slipped around -0.08 points on Monday, while shares priced at $5.44 at the close of the session, down -1.45%. Historical Performance In The News: Taking a look at the performance of Bionano Genomics, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 3.63 percent, resulting in a performance for the month at -12.02 percent. Monthly Subscription. Bionano Genomics, Inc. (Nasdaq: BNGO) announced it largest presence to date at the 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics (ACMG), which is being held in a virtual format from April 13-16, 2021. Bionano Genomics to sell more shares, stock falls MarketWatch. Bionano Genomics Inc. (NASDAQ:BNGO) went down by -3.19% from its latest closing price compared to the recent 1-year high of $15.69. Hos Nordnet kan du handle fra 0 kr. Bionano Genomics December 30, 2020 GMT. Bionano Genomics to sell more shares, stock falls MarketWatch. 05:29 PM ET . Daraus ergibt sich eine “Buy”-Einschätzung. Bionano Genomics: Erfreuliche Ereignisse! 61% höher als seine … (BNGO) Nasdaq Listed. 2 months ago - Benzinga. The stock spiked 6.35% in intraday trading to $5.98- this Tuesday, May 18, hitting a weekly high. Bionano Genomics Inc Aktie (2Y3) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen. This seems, up to now, … Market Cap. Tuesday, Jan 19, 2021. Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & Diagnostic Summit. Bionano Genomics, Inc. ist ein biowissenschaftliches Instrumentierungsunternehmen im Bereich der Genomanalyse. BIONANO GENOMICS DL-,0001 share price in real-time (A2JRLZ / US09075F1075), charts and analyses, news, key data, turnovers, company data. Technical analysis A fast and easy way to analyze US Stocks Technical analysis gauges display real-time ratings for the selected timeframes. … Growth in EPS is an important measure of administration performance because it shows how much money the company is making … Bionano Genomics, Inc. (BNGO) registered a -1.13% downside in the last session and has traded in the green over the past 5 sessions. $5.66. Real-time Level 1 for Canada + USA . BioNano Genomics Inc reported substantial advances in caring for people with autism. The recent highlights section of Bionano Genomics’ (NASDAQ: BNGO) 2021 first-quarter report said it all about BNGO stock. The jump to weekly highs of $7.37- on Monday, Apr 12 added 23.2% to the stock’s daily price. Recently in News on May 19, 2021, Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & Diagnostic Summit. Sonntag 07.02.2021 18:36 - Finanztrends Technicals Financials . Based on this estimate, we see that current price is roughly … Bionano Genomics, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $3.17 million for the quarter ended March 2021, surpassing the Zacks … Div Yield. As a spark of news events occurred leading to this rally such as an extension by the NASDAQ to regain compliance with the Bid Price Rule, third quarter earnings results and comments from analyst the stock difted higher. Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & Diagnostic Summit. Bionano Genomics wird am 13.05.2021 die Bilanz zum am 31.03.2021 abgelaufenen Quartal präsentieren. Bionano Genomics, Inc. (NASDAQ:BNGO)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.67. Die Hauptinhaber von Bionano Genomics, Inc. (NASDAQ: BNGO) Insider von Bionano Genomics, Inc. halten 0. 51% niedriger als sein 30 – Tagesdurchschnitt Handelsvolumen von 5. BIONANO GENOMICS, INC. : Veränderung des Consensus und Kursziel der Analysten der Aktie BIONANO GENOMICS, INC. | A2JRLZ | US09075F1075 | Nasdaq SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc . SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021, to regain compliance with Nasdaq's minimum $1.00 closing bid price per share requirement. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, announced the publication of the largest study of human genomes on its platform to date. It’s been quite the year for the life sciences company, Bionano Genomics (NASDAQ: BNGO).BNGO stock was trading for as little as 50 cents late … 5,51 USD. Køb Bionano Genomics, Inc. (BNGO) aktien. Nasdaq -0,10-1,78%: 11.215.193: 5,52 USD. Erik Holmlin - … Ausführliches Aktienporträt der Bionano Genomics Inc. - WKN A2JRLZ, ISIN US09075F1075 - bei finanztreff.de topaktuell! Actualmente Bionano Genomics se encuentra en un canal alcista desde hace 3 meses. Holen Sie sich die heißesten Aktien jeden Tag, bevor der Markt öffnet 100% kostenlos. BNGO forecasts Videos only. Investors had high hopes for Bionano Genomics (NASDAQ:BNGO) in the first few weeks of the year. Bionano's shares … Performance Bionano Genomics Aktie. You can read further details here. At the close of trading, the stock’s price was $5.91, to imply an increase of 9.85% or $0.53 in intraday trading. The company didn't report any news nor … U.S. stocks close at all-time highs after Biden promise of more aid offsets worst jobs report since April MarketWatch. Bionano Genomics (NASDAQ: BNGO) surged over 69% in premarket trading after the company published a study on Autism Risk Genes via its … Bionano Genomics Inc. [NASDAQ: BNGO] price surged by 3.36 percent to reach at $0.2. In the quarter ended March 31, the company shipped 11 … Aktuell handelt das Wertpapier bei einem Kurs von 11,38 USD. Lassen Sie die heißesten Aktien jeden Tag handeln, bevor der Markt öffnet % kostenlos. High volatility is … RENAISSANCE TECHNOLOGIES LLC bought a fresh place in Bionano Genomics Inc. (NASDAQ:BNGO). The company’s shares closed last Thursday at $4.41. Market Cap. Bionano Genomics (NASDAQ:BNGO) announces its next round of earnings this Tuesday, March 23. Upright in the green during last session for gaining 9.85%, in the last five days BNGO remained trading in the green while hitting it’s week-highest on Wednesday, May 26 when the stock touched $6.15-2 … Der vorherige Schlusskurs von Bionano Genomics Inc. (NASDAQ: BNGO) betrug 7 USD 83, während die ausstehenden Aktien insgesamt 278 betrugen. Bionano Genomics, Inc. (NASDAQ:BNGO) and Ocugen, Inc. (NASDAQ:OCGN) were among the early movers among biopharma stocks. Standard; Transfer of Listing. BioNano Genomics (BNGO) Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to BioNano Genomics today and set a price target of $14.00. Bionano Genomics provides unparalleled structural variation detection for genetic disease research, cancer research & cytogenomics with genome imaging technology. Bionano Genomics, Inc. (NASDAQ:BNGO)’s Biggest Investors. BNGO Bionano Genomics Aktie . Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. The company sells its flagship product called Saphyr system, which helps accelerate the … The company's market cap is currently Informieren Sie sich über die neuesten Ideen und Prognosen für BIONANO GENOMICS INC von unseren Top-Autoren - sie teilen Vorhersagen und technische Perspektiven des Marktes. 5,66 0,14 (2,54%) Upgrade auf Real-Time Nach Stunden (Geschlossen) Niedrig 0,375. Bionano Genomics (NASDAQ: BNGO) has announced that it will be reporting first-quarter 2021 results on May 13.BNGO stock caught fire at the end of 2020, peaking with a … (NASDAQ: BNGO) Bionano Genomics currently has 278,661,545 outstanding shares. NASDAQ › Bionano Genomics. It's quite possible that we're only seeing a temporary pullback. What’s left to say about Bionano Genomics (NASDAQ:BNGO) that hasn’t been said before? The big gain came after the company announced its … Free real-time prices, trades, and chat. The novel coronavirus completely altered its stock price course. Bionano Genomics Aktie (ISIN US09075F1075 / WKN 09075F107). Der Return on Capital Employed (ROCE) ist ein … Based on these … Find the latest Insider Activity data for Bionano Genomics, Inc. Common Stock (BNGO) at Nasdaq.com. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or. Some might argue that all you have to do is to look at Bionano's stock chart to see it's too late to jump on the bandwagon. 64% der Aktien bei 5. Bionano Genomics, Inc. (NASDAQ: BNGO), CorMedix Inc. (NASDAQ: CRMD) and Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) are among the health care movers Friday. Klik her for at følge aktiekursen i realtid % beim letzten Handel weist ihm eine Marktbewertung von $ zu 74.1 Million. Get the latest BioNano Genomics Inc (BNGO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. As a group, analysts anticipate that Bionano Genomics, Inc. will post -0.43 EPS for the … 2 months ago - Benzinga. The 1-year high price for the company’s stock is recorded $15.69 on 02/16/21, with the lowest value was $3.91 for the same time period, recorded on 01/08/21. Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Oppenheimer MedTech, Tools & Diagnostics Summit being held on May 26, 2021. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement. BIONANO GENOMICS INC NASDAQ. 13.01.2021 - SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) - Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq … EPS. With action -7.36%, the performance over the past five days has been red. . 31%. If this support breaks, shares could make a rapid and large move lower. 400. Div Yield. In the quarter ended March 31, the company shipped 11 … NNF Team - January 5, 2021. SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the release of EpiPanel Dx PLUS™ by its diagnostics services business, Lineagen. Dieser aktuelle Handelspreis der BNGO-Aktie beträgt – 87. However, the payoff for investing in BNGO … Stand Dezember 14, 2020, hielt das Unternehmen … Upon looking at major shareholders, it appears that insiders hold 0.03% of Bionano Genomics, Inc. shares, and 4.59% of them are in the hands of institutional investors. for … Bionano Genomics had a negative net margin of 510.42% and a negative return on equity of 749.14%. Div Yield. With Bionano Genomics stock trading at $5.52 per share, the total value of Bionano Genomics stock (market capitalization) is $1.54B.Bionano Genomics. Best deals to access real time data! Overview Ideas . 39 Handel bei – $ 0. oder -2. Die gehandelten Intraday-Aktien zählten . Bionano Genomics Announces Pre-Clinical Evaluation of Optical Genome Mapping by the Foundation for Embryonic Competence - Yahoo Finance Saturday, 27 March 2021 Back in December 2020, it was a penny stock trading for as little as $0.50. Bionano Genomics (NASDAQ:BNGO) has been one of the "get rich quick" stocks of 2021. Bionano Genomics (NASDAQ:BNGO): Q1 net loss of $9.9M; Revenue of $3.17M (+178.1% Y/Y) beats by $0.2M. Upcoming Earnings. Die gehandelten Intraday-Aktien zählten 10 1 Million, was – war . Zu den Produkten des Unternehmens gehören Sequenzierung für die Entdeckungsforschung und Zytogenetik. Bionano Genomics, Inc. (NASDAQ:BNGO) traded down 7.6% on Wednesday . Monthly Subscription. BioNano Genomics, Inc NASDAQ Updated May 25, 2021 9:04 AM. BIONANO GENOMICS, INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BIONANO GENOMICS, INC. | Nasdaq: BNGO | Nasdaq Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time to report financial results for the first quarter ended March 31, 2021 and to highlight recent SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28, 2021, to regain compliance with Nasdaq’s … Wenn wir uns die Aktie ansehen, sehen wir, dass ihr vorheriger Schlusskurs 0,7 USD betrug und das … Bionano Genomics Inc. [NASDAQ: BNGO] rutschte um -0 ab. BNGO BioNano Genomics Inc . +0.22 (+3.93%) CLOSED AT 4:00 PM ET ON May 18, 2021. Hoch 15,685. Punkte auf Montag, während Aktien bei 5 $ festgesetzt. 05:29 PM ET. Warrant (BNGOW) at Nasdaq.com. % der insgesamt ausstehenden Aktien, wobei institutionelle Inhaber 5 besitzen. The company highlighted the progress and strengths of … All time. If you had invested in Bionano Genomics stock at $6.15, your return over the last 2 years would … Bionano Genomics, Inc. (NASDAQ:BNGO) was the target of a significant increase in short interest in January. The company report on May 20, 2021 that Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & … Get the hottest stocks to trade every day before the market opens 100% free. The meeting features a total of sixteen presentations by Saphyr customers and Bionano scientists, almost three times the number presented … Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. CryptoFundManager Follow Following … 34 am Ende der Sitzung nach unten -1. 0. Shares of Bionano Genomics fell 6.43% to $5.30 at 14:28 EST on Monday, after three consecutive sessions in a row of losses. Bionano Genomics historical price data and BNGO charts. What happened Shares of Bionano Genomics (NASDAQ: BNGO) had skyrocketed 19.3% as of 11:05 a.m. EDT on Friday. In Summe, 27 Institute halten Anteile an dem Unternehmen, das von Vanguard Group, Inc. (The) geführt wird. Börsenkurse; Charts; Orderbuch; Trades; News; Finanzwerte; Historisch; Tweet. 64% Float-Prozentsatz. Bionano Genomics, Inc. (NASDAQ:BNGO) at last check was buoying at $5.89 on Thursday, May 27 with a fall of -2.16% from its closing price on previous day. There’s an … Dec 15, machte eine Aufwärtsbewegung von 21. Best deals to access real time data! Upcoming Earnings. Verkaufen. for only. The study, led by … News zur BIONANO GENOMICS AKTIE und aktueller Realtime-Aktienkurs Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & Diagnostic Summit Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2021 Results Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants. Bionano Genomics, Inc. (NASDAQ: BNGO) notierte bei der letzten Überprüfung am Montag bei 0 USD 84. The healthcare stockis down 13% from its peak set last week. Renewed interest in BioNano Genomics Inc is behind the comeback. Bionano Genomics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. 52 Week Range. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. Nasdaq's determination is based on the Company meeting the continued listing … P/E. Bionano Genomics, Inc. operates in the genome analysis industry. Bionano Genomics klar im Hausse-Modus Der aktuelle Kurs der Bionano Genomics von 11,18 USD ist mit +645,33 Prozent Entfernung vom GD200 aus Sicht der charttechnischen Bewertung ein “Buy”-Signal.